Topics:
Radiation Oncology • Neuro-Oncology
To what degree does the extent of resection (GTR v STR) of an IDH-mutated, 1p19q co-deleted, grade 3 oligodendroglioma influence survival outcomes?
Is there a role for emerging therapies such as laser ablation/LITT to any unresected residual disease prior to chemoRT?